tiprankstipranks
Trending News
More News >
Bristol-Myers Squibb Company (BMY)
:BMY
US Market
Advertisement

Bristol-Myers Squibb (BMY) Ratios

Compare
11,569 Followers

Bristol-Myers Squibb Ratios

BMY's free cash flow for Q1 2025 was $0.73. For the 2025 fiscal year, BMY's free cash flow was decreased by $ and operating cash flow was $0.31. See a summary of the company’s cash flow.
Ratios
TTM
Dec 24Dec 23Dec 22Dec 21
Liquidity Ratios
Current Ratio
1.28 1.43 1.25 1.52 1.58
Quick Ratio
1.17 1.31 1.14 1.43 1.47
Cash Ratio
0.45 0.51 0.42 0.64 0.76
Solvency Ratio
0.18 0.27 0.25 0.24 0.02
Operating Cash Flow Ratio
0.59 0.62 0.60 0.74 0.74
Short-Term Operating Cash Flow Coverage
4.03 4.44 3.06 3.28 6.01
Net Current Asset Value
$ -44.20B$ -33.90B$ -38.43B$ -40.05B$ -50.41B
Leverage Ratios
Debt-to-Assets Ratio
0.55 0.44 0.42 0.42 0.44
Debt-to-Equity Ratio
2.95 1.41 1.31 1.27 1.37
Debt-to-Capital Ratio
0.75 0.58 0.57 0.56 0.58
Long-Term Debt-to-Capital Ratio
0.73 0.55 0.53 0.52 0.56
Financial Leverage Ratio
5.32 3.23 3.12 3.04 3.13
Debt Service Coverage Ratio
2.79 4.44 3.25 3.04 0.77
Interest Coverage Ratio
4.36 14.79 8.38 7.62 3.61
Debt to Market Cap
0.53 0.37 0.26 0.32 0.36
Interest Debt Per Share
26.22 20.60 19.69 21.13 23.51
Net Debt to EBITDA
2.49 1.55 1.64 1.57 7.37
Profitability Margins
Gross Profit Margin
65.99%76.24%78.04%78.57%72.31%
EBIT Margin
17.05%21.34%19.38%20.33%-12.82%
EBITDA Margin
33.97%43.14%41.66%43.53%11.84%
Operating Profit Margin
18.45%38.31%22.37%21.90%12.06%
Pretax Profit Margin
12.82%18.75%16.71%17.46%-16.16%
Net Profit Margin
11.38%17.83%13.71%15.08%-21.16%
Continuous Operations Profit Margin
11.41%17.86%13.75%15.12%-21.16%
Net Income Per EBT
88.72%95.08%82.03%86.37%130.91%
EBT Per EBIT
69.51%48.95%74.68%79.71%-133.99%
Return on Assets (ROA)
5.86%8.43%6.53%6.40%-7.59%
Return on Equity (ROE)
31.93%27.27%20.37%19.46%-23.78%
Return on Capital Employed (ROCE)
12.85%23.65%13.78%11.62%5.16%
Return on Invested Capital (ROIC)
10.85%21.56%10.71%9.51%6.59%
Return on Tangible Assets
11.24%17.10%16.09%15.19%-20.13%
Earnings Yield
5.75%7.56%4.13%5.05%-6.42%
Efficiency Ratios
Receivables Turnover
4.41 2.95 3.31 3.71 5.00
Payables Turnover
4.05 3.28 3.33 3.37 4.34
Inventory Turnover
6.08 4.02 4.33 4.74 5.68
Fixed Asset Turnover
6.60 5.60 6.18 6.66 6.30
Asset Turnover
0.52 0.47 0.48 0.42 0.36
Working Capital Turnover Ratio
7.49 6.04 5.50 4.12 3.84
Cash Conversion Cycle
52.66 103.41 84.97 67.13 53.17
Days of Sales Outstanding
82.76 123.79 110.21 98.49 72.98
Days of Inventory Outstanding
60.06 90.87 84.22 76.93 64.30
Days of Payables Outstanding
90.16 111.24 109.46 108.29 84.11
Operating Cycle
142.82 214.66 194.43 175.42 137.28
Cash Flow Ratios
Operating Cash Flow Per Share
7.05 6.70 6.13 7.30 6.22
Free Cash Flow Per Share
6.44 6.11 5.61 6.86 5.89
CapEx Per Share
0.60 0.58 0.52 0.44 0.33
Free Cash Flow to Operating Cash Flow
0.91 0.91 0.91 0.94 0.95
Dividend Paid and CapEx Coverage Ratio
2.33 2.33 2.27 3.02 2.91
Capital Expenditure Coverage Ratio
11.69 11.46 11.69 16.66 18.66
Operating Cash Flow Coverage Ratio
0.28 0.33 0.32 0.36 0.27
Operating Cash Flow to Sales Ratio
0.30 0.31 0.28 0.35 0.33
Free Cash Flow Yield
13.85%11.92%7.80%11.00%9.49%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
17.38 13.23 24.22 19.80 -15.57
Price-to-Sales (P/S) Ratio
1.98 2.36 3.32 2.99 3.29
Price-to-Book (P/B) Ratio
5.42 3.61 4.93 3.85 3.70
Price-to-Free Cash Flow (P/FCF) Ratio
7.21 8.39 12.83 9.09 10.53
Price-to-Operating Cash Flow Ratio
6.58 7.66 11.73 8.54 9.97
Price-to-Earnings Growth (PEG) Ratio
0.11 0.43 -4.24 -0.11 0.05
Price-to-Fair Value
5.42 3.61 4.93 3.85 3.70
Enterprise Value Multiple
8.33 7.01 9.61 8.42 35.19
Enterprise Value
134.85B 136.16B 184.85B 170.10B 177.19B
EV to EBITDA
8.33 7.01 9.61 8.42 35.19
EV to Sales
2.83 3.03 4.00 3.67 4.17
EV to Free Cash Flow
10.31 10.76 15.47 11.17 13.32
EV to Operating Cash Flow
9.42 9.82 14.15 10.50 12.61
Tangible Book Value Per Share
-13.18 -9.07 -12.39 -12.28 -15.90
Shareholders’ Equity Per Share
8.56 14.22 14.58 16.18 16.75
Tax and Other Ratios
Effective Tax Rate
0.11 0.05 0.18 0.13 -0.31
Revenue Per Share
23.45 21.75 21.67 20.88 18.83
Net Income Per Share
2.67 3.88 2.97 3.15 -3.98
Tax Burden
0.89 0.95 0.82 0.86 1.31
Interest Burden
0.75 0.88 0.86 0.86 1.26
Research & Development to Revenue
0.21 0.21 0.21 0.22 0.26
SG&A to Revenue
<0.01 0.14 0.00 0.00 0.00
Stock-Based Compensation to Revenue
0.01 0.01 <0.01 0.01 0.02
Income Quality
2.63 1.72 2.06 2.31 -1.56
Currency in USD
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis